Integrated Multiomics Analysis and Experimental Validation Identify ITPRIPL1 as an Immunoregulatory and Prognostic Biomarker in Gastric Adenocarcinoma
Journal of Gastroenterology and Hepatology · 2026
DOI: 10.1111/jgh.70183 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gastroenterology and Hepatology, 2026. Verfasst von Zixuan Jia und 6 weiteren Autor:innen. Beteiligte Einrichtung: Intensive Care Unit, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen Universit…. Hauptthemen laut MEDLINE: Stomach Neoplasms, Adenocarcinoma, Biomarkers, Tumor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Scientific Research Project of Traditional Chinese Medicine Bureau of Guangdong Province, Postgraduate Project of the First People's Hospital of Kashi.
Abstract (Originalsprache)
Background
Inositol 1,4,5‐trisphosphate receptor‐interacting protein‐like 1 (ITPRIPL1) has been identified as an inhibitory ligand of CD3ε, but its role in stomach adenocarcinoma (STAD) remains unclear.
Aims
This study aims to elucidate the oncogenic and immunoregulatory roles of ITPRIPL1 in STAD. Materials and Methods Integrative bioinformatic analyses, including transcriptomic and spatial transcriptomic data, were performed to assess ITPRIPL1 expression, prognostic relevance, and immune interactions. Experimental approaches, including proliferation, migration, and invasion assays, were used to validate the functional effects.
Results
We found that ITPRIPL1 was significantly upregulated in STAD and associated with an unfavorable prognosis. Although enriched in T cell activation pathways, ITPRIPL1‐expressing tumor cells predominantly interacted with regulatory T cells (Tregs) and exhausted T cells (Tex), while showing limited communication with cytotoxic or naïve T cells. Spatial analyses revealed positive correlations between ITPRIPL1 expression and both tumor malignancy and T cell exhaustion signatures, but a negative correlation with CD274 expression. Functional assays confirmed the role of ITPRIPL1 in promoting tumor cell proliferation, migration, and invasion.
Discussion
Collectively, ITPRIPL1 promotes STAD progression by increasing tumor aggressiveness and fostering interactions with immunosuppressive T cell subsets.
Conclusion
These findings suggest that ITPRIPL1 is a potential prognostic marker and immunosuppressive target in STAD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Intensive Care Unit, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.
- First Division of Intensive Care Unit, First People's Hospital of Kashi, Kashi Prefecture, China.
- State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangdong Provincial Clinical Research Centre for Cancer, Department of Medical Oncology, Sun Yat-sen University Canc…
- State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.
- State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Key Laboratory of Infectious Diseases Research in South China, Department of Infectious Diseases, Nanfang…
ORCID-Profile: Zixuan Jia, Kangqiao Xiong, You Zhou, Shaohang Cai, Wei Liao
Förderung
- Scientific Research Project of Traditional Chinese Medicine Bureau of Guangdong Province
- Postgraduate Project of the First People's Hospital of Kashi
Zitieren
APA
Jia, Z., Xiong, K., Zhou, Y., Chen, R., Wang, D., Cai, S., & Liao, W. (2026). Integrated Multiomics Analysis and Experimental Validation Identify ITPRIPL1 as an Immunoregulatory and Prognostic Biomarker in Gastric Adenocarcinoma. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.70183
Vancouver
Jia Z, Xiong K, Zhou Y, Chen R, Wang D, Cai S, et al. Integrated Multiomics Analysis and Experimental Validation Identify ITPRIPL1 as an Immunoregulatory and Prognostic Biomarker in Gastric Adenocarcinoma. Journal of Gastroenterology and Hepatology. 2026. doi:10.1111/jgh.70183
BibTeX
@article{Jia2026,
author = {Jia, Zixuan and Xiong, Kangqiao and Zhou, You and Chen, Rong and Wang, Daofeng and Cai, Shaohang and Liao, Wei},
title = {Integrated Multiomics Analysis and Experimental Validation Identify ITPRIPL1 as an Immunoregulatory and Prognostic Biomarker in Gastric Adenocarcinoma},
journal = {Journal of Gastroenterology and Hepatology},
year = {2026},
doi = {10.1111/jgh.70183}
}
EUVIMED